Half a Million Young Veterans Have High Blood Pressure, Study Finds
April 22, 2026 — Study finds half a million post-9/11 veterans have high blood pressure, with many undiagnosed or untreated. Key disparities by sex, race, and ethnicity highlighted.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
Soligenix CEO: Patient-Centric Reformulation Is Key to Drug Success
April 21, 2026 — Soligenix CEO advocates patient-centric drug reformulation to improve treatment access and adherence for rare diseases. Learn how subcutaneous delivery transforms chronic care.
Soligenix CEO Outlines Capital Discipline Strategy for Biotech Survival
April 21, 2026 — Soligenix CEO Dr. Christopher Schaber discusses capital discipline strategies for biotech companies in constrained funding environments, emphasizing rare disease development and value-defining milestones.
Bowie Dental Practice Unites Family Care Under One Roof
April 21, 2026 — Conley Family Dentistry in Bowie, MD launches all-ages dental care model serving toddlers to seniors. Family dentist Bowie MD residents trust offers preventive, restorative & cosmetic services.
Carolina Braces Expands Orthodontic Care in Raleigh with Personalized Treatments
April 21, 2026 — Carolina Braces in Raleigh expands orthodontic services with braces, Invisalign, and early treatments for all ages. Learn about personalized care and financing options.
Oncotelic's Pipeline Valued as Financial Asset in Biotech Shift
April 21, 2026 — Oncotelic Therapeutics exemplifies biotech valuation shift, with drug pipelines recognized as financial assets under U.S. GAAP. Its 45% stake in GMP Bio, valued over $1B, highlights clinical progress enhancing balance sheets.
NanoViricides' NV-387 Drug Targets Measles Outbreak as Cases Surge Globally
April 21, 2026 — NanoViricides announces its antiviral drug NV-387 may combat the global measles outbreak, citing safety in Phase I trials and efficacy in animal models as a complement to vaccines.
Molecular Testing Revolutionizes CNS Cancer Diagnosis and Treatment
April 21, 2026 — Discover how molecular analysis is transforming CNS cancer diagnosis, with insights from CNS Pharmaceuticals and BioMedWire's role in disseminating breakthrough medical news to global audiences.
AI System Achieves Perfect Antibiotic Prescribing Accuracy in Landmark Study
April 21, 2026 — Eolas Medical's AI system achieves 100% antibiotic prescribing accuracy in Nature-published study, offering solution to antibiotic resistance crisis affecting millions.
New Oral Rinse Breaks Through Saliva Barrier to Fight Gingivitis
April 21, 2026 — ioTech International launches ioRinse Ultra, an oral rinse proven effective against gingivitis-causing bacteria in human saliva, challenging traditional mouthwash efficacy.
Carolina Braces Highlights Local Orthodontist Benefits for Raleigh Patients
April 21, 2026 — Carolina Braces educates Raleigh patients on benefits of local orthodontists for Invisalign and braces, emphasizing proximity for better treatment outcomes and convenience.
BioXgen Unveils Cardiac Patch in Investor Webinar, Opens Crowdfunding
April 21, 2026 — BioXgen announces a Regulation Crowdfunding investment offering and live webinar for its cardiac patch to prevent post-operative atrial fibrillation after open-heart surgery.
LIXTE's LB-100 Cancer Drug Shows Promise in Enhancing Chemotherapy Efficacy
April 20, 2026 — LIXTE Biotechnology's LB-100 cancer drug enhances chemotherapy effectiveness through PP2A inhibition. Clinical trials show promise for ovarian, colon cancers & sarcoma treatment improvements.
Cardio Diagnostics Revolutionizes Heart Health with AI-Powered Genetic Analysis
April 20, 2026 — Cardio Diagnostics uses AI, genetics & epigenetics to transform cardiovascular disease prevention & detection. NASDAQ: CDIO company creates personalized heart health insights.
Soligenix Gains EU Orphan Drug Status for Behçet's Disease Therapy
April 20, 2026 — Soligenix receives European Commission orphan drug designation for SGX945 targeting Behçet's disease, marking a key regulatory milestone for rare disease treatment development.
Soligenix CEO: Patient-Centric Reformulation Is Key to Drug Success
April 20, 2026 — Soligenix CEO advocates for patient-centric drug development, highlighting reformulation of SGX945 from IV to subcutaneous to improve access and adherence in rare disease treatment.
Oragenics Advances Concussion Treatment with Phase IIa Trial Progress
April 20, 2026 — Oragenics advances Phase IIa trial for ONP-002, a first-in-class intranasal treatment for concussion. Two patients enrolled in Australia trial addressing unmet need for FDA-approved mTBI therapies.
Aditxt's Ignite Proteomics Shows Breakthrough in Breast Cancer Treatment Prediction
April 20, 2026 — Aditxt subsidiary Ignite Proteomics featured in Nature study showing advanced protein analytics predict breast cancer treatment outcomes better than traditional methods.
Lantern Pharma Seeks FDA Approval for Refined Lung Cancer Trial Protocol
April 20, 2026 — Lantern Pharma schedules FDA meeting for LP-300 lung cancer trial amendments. AI-driven precision oncology company seeks to refine Phase 2 HARMONIC trial for EGFR patients.
Helus Pharma CEO Steps Down, Co-founder Takes Interim Role Amid Key Trial
April 20, 2026 — Helus Pharma announces CEO transition with Eric So as interim leader, focusing on clinical trials for mental health treatments like HLP003. Learn about the company's NSAs and impact.